1. Caution advised with weight loss products

   News item 23 April 2016 Pages: 1 - 1

2. Celecoxib safety review recommends lower dosages

   News item 23 April 2016 Pages: 2 - 2

3. FDA: metformin safe in mild to moderate renal impairment

   News item 23 April 2016 Pages: 3 - 3

4. Malignancies associated with psoriasis therapies: US results

   News item 23 April 2016 Pages: 4 - 4

5. Mycophenolate mofetil: precautions revised in Japan

   News item 23 April 2016 Pages: 5 - 5

6. PDE5 inhibitors linked to sudden hearing loss, deafness

   News item 23 April 2016 Pages: 6 - 6

7. UK NICE issues new guidance for safer use of controlled drugs

   Media release 23 April 2016 Pages: 7 - 7

8. Androgen deprivation therapy associated with depression

   Clinical study 23 April 2016 Pages: 8 - 8

9. High suppurative lymphadenitis rate following BCG vaccination

   Clinical study 23 April 2016 Pages: 9 - 9

10. Low risk of orofacial clefts with lamotrigine

    Clinical study 23 April 2016 Pages: 10 - 10

11. More checks needed to prevent medication errors in US hospitals

    Media release 23 April 2016 Pages: 11 - 11

12. Prolonged propranolol use increases mortality

    Clinical study 23 April 2016 Pages: 12 - 12

13. Adalimumab/methotrexate interaction

    Case report 23 April 2016 Pages: 13 - 13

14. Afatinib

    Case report 23 April 2016 Pages: 14 - 14

15. Aflibercept

    Case report 23 April 2016 Pages: 15 - 15

16. Albendazole

    Case report 23 April 2016 Pages: 16 - 16

17. Alectinib

    Case report 23 April 2016 Pages: 17 - 17

18. Alemtuzumab/fludarabine/melphalan

    Case report 23 April 2016 Pages: 18 - 18

19. Alendronic acid

    Case report 23 April 2016 Pages: 19 - 19

20. Allopurinol

    Case report 23 April 2016 Pages: 20 - 20

21. Amfetamine

    Case report 23 April 2016 Pages: 21 - 21

22. Amiodarone

    Case report 23 April 2016 Pages: 22 - 22

23. Amoxicillin

    Case report 23 April 2016 Pages: 23 - 23

24. Amoxicillin/clarithromycin/metronidazole/omeprazole

    Case report 23 April 2016 Pages: 24 - 24

25. Amphotericin B

    Case report 23 April 2016 Pages: 25 - 25

26. Antifungals

    Case report 23 April 2016 Pages: 26 - 26

27. Antineoplastics

    Case report 23 April 2016 Pages: 27 - 27

28. Antineoplastics

    Case report 23 April 2016 Pages: 28 - 28

29. Antineoplastics

    Case report 23 April 2016 Pages: 29 - 29

30. Antineoplastics

    Case report 23 April 2016 Pages: 30 - 30

31. Antineoplastics

    Case report 23 April 2016 Pages: 31 - 31

32. Antineoplastics/perindopril/spironolactone

    Case report 23 April 2016 Pages: 32 - 32

33. Antipsychotics

    Case report 23 April 2016 Pages: 33 - 33

34. Aspirin/clopidogrel/dalteparin sodium/heparin

    Case report 23 April 2016 Pages: 34 - 34

35. Aspirin/heparin/warfarin

    Case report 23 April 2016 Pages: 35 - 35

36. Aspirin/ticagrelor

    Case report 23 April 2016 Pages: 36 - 36

37. Atropine

    Case report 23 April 2016 Pages: 37 - 37

38. Azacitidine

    Case report 23 April 2016 Pages: 38 - 38

39. Azathioprine/prednisolone

    Case report 23 April 2016 Pages: 39 - 39

40. Bee venom

    Case report 23 April 2016 Pages: 40 - 40

41. Benzathine benzylpenicillin/penicillins

    Case report 23 April 2016 Pages: 41 - 41

42. Benzylpenicillin

    Case report 23 April 2016 Pages: 42 - 42

43. Bevacizumab

    Case report 23 April 2016 Pages: 43 - 43

44. Bevacizumab

    Case report 23 April 2016 Pages: 44 - 44

45. Bevacizumab

    Case report 23 April 2016 Pages: 45 - 45

46. Bevacizumab/irinotecan

    Case report 23 April 2016 Pages: 46 - 46

47. Botulinum toxin A

    Case report 23 April 2016 Pages: 47 - 47

48. Botulinum-toxin-A

    Case report 23 April 2016 Pages: 48 - 48

49. Brentuximab vedotin

    Case report 23 April 2016 Pages: 49 - 49

50. Bupivacaine/lidocaine

    Case report 23 April 2016 Pages: 50 - 50